Method for detecting and / or quantifying cells
The method employs a microchamber structure and containment/sealing processes to facilitate rapid and straightforward cell detection and quantification, addressing the inefficiencies of existing techniques.
Patent Information
- Application Number
- PCT/JP2026/018455
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-05-16
- Filing Date
- 2026-05-15
- Publication Date
- 2026-11-19
AI Technical Summary
Existing methods for detecting and quantifying cells are time-consuming and complex, lacking a rapid and simple approach.
A method involving a cell culture step, cell staining step, and cell detection/quantification step using a microchamber structure, with optional containment and sealing processes, including the use of a detection and/or quantification kit with microchamber structures and a medium that can attach a test sample, allowing for faster and simpler detection and quantification.
Enables quick and easy detection and quantification of cells, reducing the time required for analysis.
Smart Images

Figure JP2026018455_19112026_PF_FP_ABST
Abstract
Description
Method for detecting and / or quantifying cells
[0001] The present invention relates to a method for detecting and / or quantifying cells.
[0002] Conventionally, various test methods are known for sterility testing of products. For example, the Japanese Pharmacopoeia describes the direct method, the membrane filter method and the like as techniques for sterility testing (see Non-Patent Document 1).
[0003] Eighteenth Revised Japanese Pharmacopoeia, Ministry of Health, Labour and Welfare
[0004] Herein, an object of the present invention is to provide a novel method for detecting cells and / or quantifying cells. Further, in a preferred embodiment of the present invention, another object is to provide a more rapid and simple method for detecting cells and / or quantifying cells.
[0005] The present invention for solving the above problems is the following [1] to
[12] .
[0006] [1] A method for detecting and / or quantifying cells, comprising: a cell culture step or a cell staining step; and a cell detection step of detecting the presence or absence of cells in a microchamber structure and / or a cell quantification step of quantifying the cells. This is the method for detecting and / or quantifying cells.
[0007] [2] The method for detecting and / or quantifying cells according to [1], further comprising a containing step of containing a test sample in the microchamber structure before the cell culture step or before the cell staining step, wherein the containing step includes a sealing treatment of sealing with an oily sealing material.
[0008] [3] The method for detecting and / or quantifying cells according to [1] or [2], further comprising a containing step of containing a test sample in the microchamber structure before the cell culture step or before the cell staining step, wherein the containing step includes a containing treatment of containing the test sample into the microchamber structure via a medium to which the test sample is attached on the microchamber structure.
[0009] [4] The method for detecting and / or quantifying cells according to any one of [1] to [3], wherein 50 to 100 million microchamber structures are arranged, the volume of the microchamber structures is 0.01 femtoliters to 500 nanoliters, and the microchamber structures are arranged on the surface of a solid culture medium.
[0010] [5] A method for detecting and / or quantifying cells according to any one of [1] to [4], wherein 50 to 100 million microchamber structures are arranged, the volume of the microchamber structures is 0.01 femtoliters to 500 nanoliters, the medium is a membrane filter or adhesive tape, and the microchamber structures are arranged on the surface of a solid culture medium.
[0011] [6] A cell detection and / or quantification method according to any one of [1] to [5], further comprising: a first test sample information acquisition step of obtaining first test sample information relating to the test sample before the cell culture step after the containment step; and a second test sample information acquisition step of obtaining second test sample information relating to the test sample after the cell culture step, wherein the cell detection step includes a step of comparing the first test sample information and the second test sample information to determine that cells are present in the test sample if cells have proliferated in at least one of the microchamber structures; and the cell quantification step includes a measurement process of measuring the number of microchamber structures in which the target cell species exists based on the first test sample information and / or the second test sample information; and a quantification process of quantifying the cells in the test sample based on the increase in the number of microchamber structures in which the target cell species exists.
[0012] [7] A method for detecting and / or quantifying cells as described in any one of [1] to [6], wherein the first test sample information and the second test sample information are image information of a microchamber structure, fluorescence information within the microchamber structure, luminescence information within the microchamber structure, absorbance information within the microchamber structure, light intensity information within the microchamber structure, and / or turbidity information within the microchamber structure.
[0013] [8] The containment step includes a containment process, the containment process being a process of containing the sample in the microchamber structure by grounding the medium to which the sample has been attached, using a detection and / or quantification kit that includes a substrate having a microchamber structure and a medium to which the sample can be attached, or the containment process being a process of containing the sample in the microchamber structure by attaching the sample to the medium, using a detection and / or quantification kit that includes a medium to which the sample can be attached and which has a microchamber structure, the sample being attached to the medium, the cell detection and / or quantification method according to any one of [1] to [7].
[0014] The above method allows for faster and simpler detection and / or quantification of cells.
[0015] [9] A detection and / or quantification kit for detecting and / or quantifying cells, comprising a substrate having a microchamber structure, and a medium or oily sealant to which a test sample can adhere, or a medium to which a test sample can adhere and which has a microchamber structure.
[0016] A kit having the above configuration allows for faster and simpler detection and / or quantification of cells.
[0017]
[10] A detection and / or quantification device for detecting and / or quantifying cells, comprising: a substrate having a microchamber structure; a measurement target placement section on which a measurement target having a medium or oily sealant to which a test sample can adhere, or a medium to which a test sample can adhere and which has a microchamber structure; a base section having at least one of the measurement target placement sections; and an information acquisition means placement section on which a test sample information acquisition means for obtaining test sample information relating to the test sample from the measurement target placed in the measurement target placement section can be arranged, wherein the base section has a movable mechanism that allows the measurement target placement section to be moved to a position corresponding to the information acquisition means placement section, and is also a cell detection and / or quantification device.
[0018] The apparatus having the above configuration allows for rapid and simple detection and / or quantification of cells.
[0019]
[11] A solid culture medium for cell detection and / or quantification, wherein the solid culture medium is arranged with 50 to 100 million microchamber structures, and the volume of the microchamber structures is 0.01 femtoliters to 500 nanoliters.
[0020] By using a solid culture medium having the above configuration, cells can be detected and / or quantified quickly and easily.
[0021]
[12] A method for producing a solid culture medium, comprising forming a microchamber structure in the solid culture medium using a mold having a volume of 0.01 femtoliters or more and 500 nanoliters or less, and containing 50 to 100 million microchamber-forming structures, the method for producing a solid culture medium for cell detection and / or quantification.
[0022] By using the solid culture medium obtained by the above manufacturing method, cells can be detected and / or quantified quickly and easily.
[0023] According to the present invention, cell detection and / or cell quantification can be performed more quickly and easily.
[0024] Figure 1 is a diagram showing a flow chart according to one embodiment of the cell detection and / or quantification method of the present invention. Figure 2 is a schematic diagram showing one embodiment of the containment step. Figure 3 is a schematic diagram showing one embodiment of the containment step. Figure 4 is a schematic diagram showing one embodiment of the containment step. Figure 5 is a schematic diagram showing one embodiment of the containment step. Figure 6 is a schematic diagram showing one embodiment of the containment step. Figure 7 is a schematic diagram showing one embodiment of the containment step. Figure 8 is a schematic diagram according to one embodiment of the cell detection and / or quantification apparatus of the present invention. Figure 9 shows the observation results of a substrate having a microchamber structure (A-1 to A-3) and a substrate without a microchamber structure (B-1 to B-3) 9 hours after the containment step in Example 1 of the present invention. The arrows indicate microchamber structures in which colony formation was confirmed. The scale bar represents 200 μm. Figure 10 shows the observation results of a substrate with a microchamber structure (A-1 to A-3) and a substrate without a microchamber structure (B-1 to B-3) 12 hours after the containment process in Example 1 of the present invention. The scale bar represents 200 μm. Figure 11 shows the observation results of a substrate with a microchamber structure (A-1 to A-3) and a substrate without a microchamber structure (B-1 to B-3) 15 hours after the containment process in Example 1 of the present invention. The scale bar represents 200 μm. Figure 12 shows the observation results of a substrate with a microchamber structure (A-1 to A-3) and a substrate without a microchamber structure (B-1 to B-3) 16 hours after the containment process in Example 1 of the present invention. The scale bar represents 200 μm. Figure 13 shows the results of observing the proliferation of cells targeted for detection and / or quantification from 0 to 24 hours after the containment step in Example 2 of the present invention, on a substrate without a microchamber structure in the absence of an oily sealant, at one-hour intervals. The scale bar represents 100 μm. Figure 14 shows the results of observing the proliferation of cells targeted for detection and / or quantification from 0 to 24 hours after the containment step in Example 2 of the present invention, on a substrate without a microchamber structure in the presence of an oily sealant, at one-hour intervals. The scale bar represents 100 μm.Figure 15 shows the results of observing the proliferation of cells targeted for detection and / or quantification 0 to 24 hours after the containment step in Example 2 of the present invention, using a substrate having a microchamber structure in the presence of an oily encapsulant, at one-hour intervals. The scale bar represents 100 μm. Figure 16 shows the analysis results of Figure 13 in Analysis Example 1 of the present invention. Figure 17 shows the analysis results of Figure 14 in Analysis Example 1 of the present invention. Figure 18 shows the analysis results of Figure 15 in Analysis Example 1 of the present invention. Figure 19 shows the results of observing the proliferation of cells targeted for detection and / or quantification 7 hours, 8 hours, and 9 hours after the containment step in a substrate having a microchamber structure in the presence of each oily encapsulant, in Example 3 of the present invention. The arrows indicate microchamber structures in which colony formation was confirmed. The scale bar represents 100 μm.
[0025] Preferred embodiments of the present invention will be described below, but the technical scope of the present invention is not limited to the following embodiments.
[0026] <1> Method for detecting and / or quantifying cells The method of the present invention is a method for detecting and / or quantifying cells in a test sample. The method of the present invention is characterized by comprising a cell culture step or a cell staining step, and a cell detection step for detecting the presence or absence of cells in a microchamber structure and / or a cell quantification step for quantifying the cells.
[0027] A more preferred embodiment of the method of the present invention comprises a containment step of containing a test sample in a microchamber structure, a cell culture step or a cell staining step, a cell detection step for detecting the presence or absence of cells in the microchamber structure and / or a cell quantification step for quantifying the cells, wherein the containment step includes a sealing process of sealing with an oily sealant.
[0028] By adopting the above configuration, cells can be detected and / or quantified quickly and easily.
[0029] Furthermore, one more preferred embodiment of the method of the present invention comprises a containment step of containing a test sample in a microchamber structure, a cell culture step or a cell staining step, a cell detection step for detecting the presence or absence of cells in the microchamber structure and / or a cell quantification step for quantifying the cells, wherein the containment step includes a containment process of containing the test sample in the microchamber structure via a medium on which the test sample is attached.
[0030] By adopting the above configuration, cells can be detected and / or quantified quickly and easily.
[0031] <1-1> Preferred Embodiments of Each Configuration First, preferred embodiments of the present invention will be described in detail for each configuration.
[0032] (1) With respect to the test sample, in this specification, the test sample refers to a sample that may contain cells to be detected and / or quantified. Examples of test samples include biological samples such as saliva and blood, pharmaceuticals, foods such as meat and vegetables, drinking water, soil and river water, and cell culture media. Among these, the test sample is preferably a cell culture media.
[0033] Here, the cell culture medium may be any of the following: unused cell culture medium, cell culture medium used for cell culture, or cell culture medium currently being used for cell culture.
[0034] (2) Examples of cells to be detected and / or quantified include mammalian cells, avian cells, amphibian cells, microbial cells, and insect cells. Among these, it is preferable that the cells to be detected and / or quantified be microbial cells.
[0035] Examples of microbial cells include bacterial, yeast, and fungal cells. Among these, bacterial and / or fungal cells are preferred as the target of detection and / or quantification.
[0036] Here, examples of fungi include Aspergillus brasiliensis, Candida albicans, and the like.
[0037] Bacterial cells may be any of aerobic bacterial cells or anaerobic bacterial cells.
[0038] Here, examples of aerobic bacteria include bacteria of the genus Legionella, bacteria of the genus Campylobacter, Staphylococcus aureus, Pseudomonas aeruginosa, Bacillus subtilis, and the like.
[0039] In addition, examples of anaerobic bacteria include bacteria of the genus Salmonella, Clostridium sporogenes, Escherichia coli, Shigella sonnei (Group D Shigella), Vibrio parahaemolyticus, Bacillus cereus, Enterobacter sakazakii, and the like.
[0040] (3) Substrate or Medium (3-1) Substrate As used herein, the substrate refers to a member that has a microchamber structure and is used for measurement.
[0041] The material of the substrate in the present embodiment preferably uses a material that has optical transparency and exhibits low autofluorescence, low wavelength dispersion, and / or low optical error.
[0042] Examples of materials that have optical transparency and exhibit low autofluorescence, low wavelength dispersion, and / or low optical error include glass, and plastics such as PP, PC, PS, COC, COP, PDMS, PMMA, PET, and PVC.
[0043] The overall width of the substrate is preferably 1 mm or more, more preferably 10 mm or more, and even more preferably 20 mm or more. In addition, the overall width of the substrate can be set to a reference of preferably 100 mm or less, more preferably 50 mm or less, and even more preferably 35 mm or less.
[0044] The overall length of the substrate is preferably 1 mm or more, more preferably 10 mm or more, and even more preferably 20 mm or more. In addition, the overall length of the substrate can be set to a reference of preferably 100 mm or less, more preferably 50 mm or less, and even more preferably 35 mm or less.
[0045] The overall thickness of the substrate is preferably 0.1 mm or more, more preferably 1 mm or more. In addition, the overall thickness of the substrate can be set to a reference of preferably 10 mm or less, more preferably 5 mm or less, and even more preferably 3.5 mm or less.
[0046] However, in the present invention, the size and shape of the substrate are not particularly limited.
[0047] The material of the substrate in the present embodiment may be a solid medium.
[0048] Here, the solid medium contains gelatin, agar and / or agarose, and a cell culture solution.
[0049] In the total amount of the solid medium, the content by mass of gelatin, agar and / or agarose is preferably 5 mass% or less, more preferably 4.5 mass% or less, even more preferably 4 mass% or less, still more preferably 3 mass% or less, and further more preferably 2 mass% or less. In addition, in the total amount of the solid medium, the content by mass of gelatin, agar and / or agarose is preferably 0.1 mass% or more, more preferably 0.2 mass% or more, even more preferably 0.5 mass% or more, and still more preferably 1 mass% or more.
[0050] By using a solid medium as the material of the substrate, a microchamber structure can be provided on the surface of the solid medium. For this reason, cells can be detected and / or quantified without using a separate medium.
[0051] In addition, the substrate in the present embodiment may be a membrane filter.
[0052] By using a membrane filter as the substrate, a microchamber structure can be provided on the surface of the membrane filter. Therefore, cell detection and / or quantification can be performed without using a separate membrane filter.
[0053] (3-2) With respect to the medium, in this specification, the medium is a member that can concentrate and attach the test sample or a member to which the test sample can be attached.
[0054] In this context, preferred media include membrane filters or adhesive tapes.
[0055] The adhesive tape is preferably one that can adhere to the cells to be detected and / or quantified.
[0056] Here, the adhesive material used in the adhesive tape may be rubber-based, acrylic-based, silicone-based, etc., and it is preferable that it does not substantially inhibit the survival or growth of cells.
[0057] Furthermore, from the standpoint of ease of observation, it is preferable that the adhesive tape itself be transparent.
[0058] It is preferable to use a water-insoluble porous membrane with a size that prevents the cells to be detected and / or quantified from passing through.
[0059] The lower limit of the pore size of the membrane filter is preferably 0.1 μm or larger, more preferably 0.15 μm or larger, more preferably 0.2 μm or larger, more preferably 0.22 μm or larger, and more preferably 0.35 μm or larger.
[0060] The upper limit of the pore size of the membrane filter is preferably 1 μm or less, more preferably 0.8 μm or less, more preferably 0.7 μm or less, and more preferably 0.65 μm or less.
[0061] By setting the pore size of the membrane filter to the above configuration, the cells to be detected and / or quantified can be attached to the membrane filter.
[0062] Materials for membrane filters include polycarbonate, nonwoven fabric, nitrocellulose, a mixture of cellulose acetate and nitrocellulose, nylon, PVDF, PTFE, MCE, PES, polypropylene, polyvinylidene fluoride, quartz, and silver.
[0063] (4) Microchamber structure In this specification, a microchamber structure is a structure provided as a recess on the surface of a substrate. In the present invention, the region on the substrate in which the microchamber structure is provided is not particularly limited as long as it is smaller than the entire substrate.
[0064] In this embodiment, the lower limit of the volume of the microchamber structure is preferably 0.01 femtoliters or more, more preferably 0.05 femtoliters or more, more preferably 0.1 femtoliters or more, more preferably 0.25 femtoliters or more, more preferably 0.5 femtoliters or more, more preferably 0.8 femtoliters or more, and more preferably 1 femtoliter or more.
[0065] In this embodiment, the upper limit of the volume of the microchamber structure is preferably 500 nanoliters or less, more preferably 250 nanoliters or less, more preferably 100 nanoliters or less, and more preferably 50 nanoliters or less.
[0066] In this embodiment, the lower limit of the number of microchamber structures is preferably 50 or more, more preferably 100 or more, more preferably 500 or more, more preferably 1000 or more, and more preferably 10,000 or more.
[0067] In this embodiment, the upper limit of the number of microchamber structures is preferably 100 million or less, more preferably 10 million or less, more preferably 5 million or less, and more preferably 1 million or less.
[0068] In this embodiment, the lower limit of the spacing between the microchamber structures is preferably 5 μm or more, more preferably 6 μm or more, and more preferably 6.5 μm or more.
[0069] In this embodiment, the upper limit of the spacing between the microchamber structures is preferably 500 μm or less, more preferably 250 μm or less, more preferably 100 μm or less, more preferably 50 μm or less, more preferably 10 μm or less, more preferably 8 μm or less, and more preferably 7.5 μm or less.
[0070] Furthermore, there are no particular restrictions on the shape of the depression in the microchamber structure; for example, cylindrical, prismatic, pyramidal, conical, or elliptical prism shapes can be used.
[0071] Here, the means for forming the microchamber structure on the substrate can be any known method, such as general-purpose photolithography (as described in Japanese Patent Publication No. 2023-034431), microfabrication by cutting, injection molding, or nanoimprint lithography.
[0072] Furthermore, the means for forming the microchamber structure on the substrate may be known methods, such as general-purpose photolithography (as described in Japanese Patent Publication No. 2023-034431), microfabrication by cutting or injection molding, or nanoimprinting, to form a mold having a microchamber formation structure, and then using the mold to form the microchamber structure on the substrate.
[0073] By using a substrate having the microchamber structure described above, cells can be easily detected and / or quantified even with a small sample size.
[0074] (5) Regarding sealing material, in this specification, sealing material is a material used to seal the sample to be tested into a microchamber structure.
[0075] The sealing material described above may be either an oil-based or aqueous sealing material, but an oil-based sealing material is preferred. By using an oil-based sealing material, the oil-based sealing material does not mix with the culture medium of the cells to be detected and / or quantified, which contains the test sample, and the test sample can be sealed into the microchamber structure.
[0076] Examples of oily sealants include mineral oil, edible oils and fats, polysaccharides, aliphatic carbonates, glycerin fatty acid esters, sorbitan fatty acid esters, fatty acid esters, and fluorinated liquids. In particular, the oily sealant is preferably one or more selected from the group consisting of aliphatic carbonates, mineral oil, edible oils and fats, fluorinated liquids, and mixtures thereof.
[0077] Furthermore, examples of aliphatic carbonates include diethylhexyl carbonate, dioctyl carbonate, dipropylheptyl carbonate, diethyl carbonate, dimethyl dicarbonate, dicaprylyl carbonate, dihexyl carbonate, and dipropyl carbonate. Among these, diethylhexyl carbonate is preferred as the aliphatic carbonate. Examples of commercially available diethylhexyl carbonate include TEGOSOFT® DEC (manufactured by Evonik Operations GmbH).
[0078] Furthermore, examples of mineral oils include paraffinic hydrocarbons, naphthenic hydrocarbons, petrolatum, gelling hydrocarbons, ceresin, hydrogenated polyisobutene, and mixtures thereof.
[0079] Furthermore, while the edible oil may be either animal fat or vegetable fat, it is preferable that the edible oil be vegetable fat.
[0080] Examples of vegetable oils include olive oil, walnut oil, palm oil, rapeseed oil, castor oil, coconut oil, soybean oil, safflower oil, sesame oil, rice bran oil, corn oil, and mixtures thereof. Among these, olive oil is preferred.
[0081] Furthermore, examples of fluorinated liquids include hydrofluoroethers (HFE) and perfluoropolyethers (perfluorinated polyethers, PFPE). Among these, perfluoropolyethers are preferred as the fluorinated liquid. Here, examples of commercially available perfluoropolyethers include Fomblin® oil (manufactured by Solvay S.A., Cat: YL VAC 06 / 6).
[0082] Furthermore, the oil-based encapsulant used in the embodiments of the present invention may be either a hydrophobic oil-based encapsulant or a hydrophilic oil-based encapsulant, but a hydrophobic oil-based encapsulant is preferred.
[0083] Examples of hydrophobic oil-based sealants include the sealants mentioned above.
[0084] Alternatively, the oil-based sealant used in the embodiments of the present invention is preferably a non-volatile oil-based sealant that does not evaporate at room temperature (25°C).
[0085] Examples of non-volatile oil-based encapsulants include the encapsulants mentioned above.
[0086] The sealing material used in the embodiments of the present invention is not particularly limited as long as it does not substantially inhibit the proliferation of the cells to be detected and / or quantified. Here, "not substantially inhibiting the proliferation of the cells to be detected and / or quantified" means that when the cells to be detected and / or quantified are cultured in the presence of the sealing material, there is no statistically significant difference in the proliferation rate compared to when the cells to be detected and / or quantified are cultured in the absence of the sealing material, or even if there is a statistically significant difference in the proliferation rate between the presence and absence of the sealing material, it does not affect the purpose of detection and / or quantification.
[0087] Examples of sealing materials that do not substantially inhibit the proliferation of cells to be detected and / or quantified include the sealing materials mentioned above.
[0088] The above-mentioned sealing material may be in the form of a liquid, solid, or semi-solid, but it is preferably a liquid (sealing liquid).
[0089] By using the above-described sealing material, cells can be detected and / or quantified quickly and easily.
[0090] <1-2> The steps of the cell detection and / or quantification method will be described below with reference to Figures 1 to 5.
[0091] A preferred embodiment of the cell detection and / or quantification method of the present invention is characterized by comprising a cell culture step or a cell staining step, and a cell detection step for detecting the presence or absence of cells in a microchamber structure and / or a cell quantification step for quantifying the cells.
[0092] Furthermore, a more preferred embodiment of the cell detection and / or quantification method of the present invention is characterized by comprising a containment step, a cell culture step or a cell staining step, and a cell detection step and / or a cell quantification step for detecting the presence or absence of cells in a microchamber structure.
[0093] (1) Containment Step (Figure 1 S1) First, the containment step S1 will be explained with reference to Figures 1 to 5. In this specification, the containment step S1 is the step of containing the test sample in a microchamber structure.
[0094] Here, a more preferred form of the containment process S1 includes a containment process and a sealing process. The containment process is a process of containing the test sample in a microchamber structure. The sealing process is a process of sealing the test sample in a microchamber structure.
[0095] One preferred embodiment of the containment process of the present invention is a process of containing the test sample in a microchamber structure via a medium to which the test sample is attached. Another preferred embodiment of the sealing process of the present invention is a process of sealing the test sample in the microchamber structure with the medium.
[0096] Here, the receiving process, in which the sample to be tested is placed in the microchamber structure via a medium to which the sample is attached, and the sealing process, in which the sample is sealed in the microchamber structure with the medium, are not limited to a specific embodiment. For example, the following embodiments can be given.
[0097] In this embodiment, as shown in Figure 2, the containment process is preferably a process in which the culture medium 24 is supplied into the microchamber structure 22 before the medium 21 to which the test sample is attached is brought into contact with the substrate 23 having the microchamber structure 22, and the medium 21 to which the test sample is attached is brought into contact with the substrate 23 having the microchamber structure 22, thereby containing the test sample in the microchamber structure 22. Then, as shown in Figure 2, the sealing process is preferably a process in which the medium 21 to which the test sample is attached is brought into contact with the substrate 23 having the microchamber structure 22, thereby sealing the test sample in the microchamber structure.
[0098] In another embodiment, as shown in Figure 3, the containment process may involve placing the medium 21 to which the test sample is attached onto a substrate 23 having a microchamber structure 22, and then supplying the culture medium 24 from above the medium 21 to which the test sample is attached, thereby containing the test sample in the microchamber structure 22. Then, as shown in Figure 3, the sealing process may involve placing the medium 21 to which the test sample is attached onto the substrate 23 having a microchamber structure 22, thereby sealing the test sample in the microchamber structure.
[0099] As in another embodiment, as shown in Figure 4, the containment process may involve placing the medium 21 to which the test sample is attached onto a substrate 23 having a microchamber structure 22 on the surface of a solid culture medium, and containing the test sample in the microchamber structure 22. Then, as shown in Figure 4, the sealing process may involve placing the medium 21 to which the test sample is attached onto a substrate 23 having a microchamber structure 22 on the surface of a solid culture medium, thereby sealing the test sample in the microchamber structure.
[0100] Furthermore, in another embodiment, as shown in Figure 5, the containment process may be a process in which the sample to be tested 31 is placed on a medium 21 to which the sample to be tested 31 can adhere and which has a microchamber structure 22, and the sample to be tested is contained in the microchamber structure 22. Then, as shown in Figure 5, the sealing process may be a process in which the sample to be tested 31 is sealed in the microchamber structure by placing the medium 21 having the microchamber structure 22 on the sample to be tested 31.
[0101] More specifically, as shown in Figure 5, the containment process may be a process in which the sample to be tested is contained in the microchamber structure 22 by grounding a medium 21 having a microchamber structure 22 on a substrate 23 that does not have a microchamber structure 22, to which the sample to be tested can adhere. Then, as shown in Figure 5, the sealing process may be a process in which the sample to be tested is sealed in the microchamber structure by placing a medium 21 having a microchamber structure 22 on a substrate 23 that does not have a microchamber structure 22, to which the sample to be tested can adhere.
[0102] In the embodiment shown in Figure 5, the substrate 23 may be a solid culture medium 24.
[0103] In addition, in the embodiment shown in Figure 5, the culture medium 24 may be supplied from above the medium 21.
[0104] Furthermore, the containment process may involve using a detection and / or quantification kit that includes a substrate having a microchamber structure and a medium to which the test sample can adhere, and placing the medium to which the test sample adheres onto the substrate having the microchamber structure, thereby containing the test sample in the microchamber structure. The sealing process may also involve placing the medium to which the test sample adheres onto the substrate having the microchamber structure, thereby sealing the test sample in the microchamber structure.
[0105] Alternatively, the containment process may involve using a detection and / or quantification kit that includes a medium to which the test sample can adhere and which has a microchamber structure, and containing the test sample in the microchamber structure by adhering the test sample to the medium. The sealing process may also involve placing the test sample on the medium having a microchamber structure to seal the sample in the microchamber structure.
[0106] Furthermore, the storage process S1 may include a step of sealing the contents with a film or the like after the sealing process.
[0107] By sealing the microchamber with a film or similar material, it is possible to prevent airborne microorganisms and other contaminants from entering the microchamber structure.
[0108] Here, the medium to which the test sample is attached used in the containment step S1 can be either one that has been prepared in advance or one that has been prepared by a cell attachment step (not shown) described later.
[0109] The cell attachment step is the process of creating a medium to which the test sample to be used in the containment step S1 is attached. In this invention, the cell attachment step may be performed before the containment step S1.
[0110] Methods for attaching the test sample to the medium include, if the test sample is solid at room temperature, methods such as allowing the test sample and the medium to come into contact for a certain period of time.
[0111] Furthermore, if the test sample is solid at room temperature, the solid test sample may be directly and aseptically dissolved in a liquid.
[0112] Furthermore, if the test sample is a liquid, or if a test sample that is solid at room temperature is dissolved in a liquid, the medium may be immersed in the liquid for a certain period of time, or the liquid may be filtered through the medium. Among these, filtering the liquid with a membrane filter is preferred.
[0113] By filtering the liquid through a membrane filter, the cells to be detected and / or quantified can be concentrated on the membrane filter.
[0114] One preferred embodiment of the containment process of the present invention is a process in which the test sample is contained in the microchamber structure by adding the test sample to the microchamber structure. Another preferred embodiment of the sealing process of the present invention is a process in which the test sample is sealed in the microchamber structure with a sealing material. Another preferred embodiment of the present invention is that a drying process may be performed before the sealing process.
[0115] Here, the containment process, in which the test sample is added to the microchamber structure to house the test sample, and the sealing process, in which the test sample is sealed in the microchamber structure with a sealing material, are not limited to any particular embodiment. For example, the following embodiments can be given.
[0116] For example, in one embodiment, as shown in Figure 6, the containment process may be a process in which the test sample 31 is contained by adding it to a substrate 23 having a microchamber structure 22 on the surface of a solid culture medium. The sealing process may be a process in which the test sample is sealed in the microchamber structure by applying or adding a sealing material 51 to the substrate 23. Here, the sealing material is preferably an oil-based sealing material. In addition, if necessary, a drying process may be performed before the sealing process. By performing a drying process, the liquid contained in the test sample 31 can be evaporated into the air, and the cells 25 contained in the test sample 31 can be reliably contained in the microchamber structure 22.
[0117] Alternatively, as shown in Figure 7, one embodiment may involve a containment process in which the test sample 31 and culture medium 24 are added to a substrate having a microchamber structure 22 to contain the test sample 31. The sealing process may involve sealing the test sample 31 in the microchamber structure 22 by coating or adding a sealing material 51 to the substrate 23. Here, the sealing material 51 is preferably an oil-based sealing material. Furthermore, the culture medium 24 is preferably a medium suitable for the proliferation of cells to be detected and / or quantified.
[0118] Furthermore, the containment process may involve adding the sample to the microchamber structure using a detection and / or quantification kit that includes a substrate having a microchamber structure and a sealing material, thereby containing the sample in the microchamber structure. The sealing process may also involve coating or adding a sealing material to the substrate, thereby sealing the sample in the microchamber structure. Here, the sealing material is preferably an oil-based sealing material.
[0119] By performing the containment step S1 in the manner described above, cells can be detected and / or quantified quickly and easily.
[0120] (2) Cell culture process or cell staining process (Figure 1 S2) Next, the cell culture process or cell staining process S2 will be explained with reference to Figure 1.
[0121] (2-1) Cell Culture Process First, we will explain the cell culture process S2.
[0122] (2-1-1) Regarding the cell culture medium, the culture medium used in cell culture step S2 may be an appropriate medium depending on the cells to be detected and / or quantified and the conditions for detection and / or quantification.
[0123] Such culture media may be any medium commonly used for culturing microorganisms, or any medium commonly used for mammalian cells, avian cells, amphibian cells, etc.
[0124] Culture media commonly used for culturing microorganisms include nutrient broth medium, Sabouraud glucose medium, Rappaport-basiliasis-salmonella enrichment medium, Mueller-Hinton medium, thioglycolic acid medium, Mosel enterobacteria enrichment broth medium, selenite-cystine medium, lactose broth medium, R2A medium, MacConkey medium, standard medium, tetrathionate medium, Rappaport medium, soybean-casein digest medium, LB medium, liquid thioglycolic acid medium, M9 medium, SOB medium, SOC medium, TB medium, 2×YT medium, NZCYM medium, or mixtures thereof.
[0125] The culture medium used in the cell culture process may be in liquid form, or it may be a solid medium obtained by mixing gelatin, agar, and / or agarose with a liquid medium and letting it solidify.
[0126] Furthermore, the culture medium used in the cell culture process may be one that has been treated anaerobically by methods such as oxygen scavenging, degassing, or inert gas replacement.
[0127] (2-1-2) Period and conditions of the cell culture process The upper limit of the period of the cell culture process S2 is preferably less than 14 days, more preferably 12 days or less, more preferably 10 days or less, more preferably 8 days or less, more preferably 6 days or less, more preferably 4 days or less, more preferably 3 days or less, more preferably less than 3 days, more preferably 2 days or less, more preferably less than 2 days, more preferably 1 day or less, more preferably less than 1 day, more preferably 20 hours or less, more preferably 16 hours or less, more preferably 12 hours or less, more preferably 10 hours or less, more preferably 8 hours or less, more preferably 6 hours or less, and more preferably 5 hours or less.
[0128] By setting the upper limit of the duration of cell culture step S2 to the above range, cell detection and / or quantification become possible more quickly and easily.
[0129] The lower limit of the duration of cell culture step S2 is preferably 10 minutes or more, more preferably 20 minutes or more, more preferably 1 hour or more, more preferably 2 hours or more, more preferably 3 hours or more, and more preferably 4 hours or more.
[0130] By setting the lower limit of the duration of cell culture step S2 to the above range, highly accurate cell detection and / or cell quantification becomes possible.
[0131] There are no particular restrictions on temperature or other conditions in cell culture step S2; any conditions that allow the cells to be detected and / or quantified to grow are acceptable.
[0132] For example, if the cells to be detected and / or quantified are fungi, it is preferable to carry out the procedure at a temperature between 20°C and 25°C.
[0133] Furthermore, if the cells to be detected and / or quantified are bacteria, it is preferable to perform the procedure at a temperature between 30°C and 35°C.
[0134] Furthermore, regardless of the cells being detected and / or quantified, the lower limit of the temperature in the cell culture step S2 may be preferably 20°C or higher, more preferably 25°C or higher, more preferably 28°C or higher, and more preferably 30°C or higher.
[0135] Furthermore, regardless of the cells to be detected and / or quantified, the upper limit of the temperature in the cell culture step S2 may preferably be 50°C or lower, more preferably 45°C or lower, more preferably 42°C or lower, and more preferably 40°C or lower.
[0136] Other conditions for cell culture step S2 include performing the process under aerobic or anaerobic conditions.
[0137] By performing the cell culture step S2 in the manner described above, cells can be detected and / or quantified quickly and easily.
[0138] (2-2) Cell staining process Next, the cell staining process S2 will be explained.
[0139] Cell staining step S2 is a step in which cells are stained using a method for staining cells.
[0140] Here, the cell staining step S2 may include a preliminary cell culture step before staining the cells. It is preferable that the preliminary cell culture step be carried out under the same conditions as the cell culture step S2 described above.
[0141] Here, the cell staining step S2 may involve fixing the cells using paraformaldehyde, glutaraldehyde, alcohol, dimethyl sveriminoate, etc., before staining the cells or after the pre-culture step.
[0142] There are no particular restrictions on the methods used to stain cells, as long as they are commonly practiced, but examples include Gram staining, Ziehl-Neelsen staining, fluorescence staining, and immunocytochemistry.
[0143] Examples of staining agents used to fluorescently stain cells in the fluorescent staining method include CTC (5-cyano-2,3-ditolyl tetrazolium chloride), FDA (fluorescein diaceate), CFDA (6-carboxyfluorescein diaceate), Calcein-AM (calcein-acetoxymethylester), acridine orange, Hoechst 33258, CFDA-AM (carboxyfluorescein diaceate-acetoxymethylester), SYBR Green, and Hoechst 33342.
[0144] Furthermore, antibodies used in immunocytochemistry can be self-produced or commercially available antibodies can be used. Also, only one or more types of antibodies are required for immunocytochemistry. By using antibodies specific to the target cells, it is possible to detect and / or quantify the target cells.
[0145] By performing the cell staining step S2 in the manner described above, cells can be detected and / or quantified quickly and easily.
[0146] (3) Cell detection step and / or cell quantification step (Figure 1 S3) Next, the cell detection step and / or cell quantification step S3 will be described with reference to Figure 1. The cell detection step and / or cell quantification step S3 is a step to detect the presence or absence of cells in the microchamber structure and / or to quantify the cells. Here, it is preferable that the cell detection step and / or cell quantification step S3 is a form in which cells are detected and / or quantified based on the second test sample information acquisition step (and the first test sample information acquisition step) which will be described later.
[0147] In this case, the cell detection preferably includes a step of determining that cells are present in the test sample if cells are proliferating in at least one microchamber structure relative to the total number of microchamber structures.
[0148] Furthermore, cell quantification can be performed by determining the concentration of cells in the test sample based on the number of microchamber structures in which cells were detected. Specifically, for example, a method for determining the concentration of cells in a test sample is to multiply the volume of the test sample attached to the medium, or the volume of the added test sample by X (cm²). 3 Let A (cells / cm³) be the number of microchamber structures in which cells were detected. In this case, the cell concentration in the test sample is A (cells / cm³). 3 The following formula can be used to calculate the value of A = Y / X(cells / cm): 3 )
[0149] In this embodiment, it is preferable to include a step of obtaining test sample information about the test sample after the cell culture step (hereinafter referred to as the second test sample information acquisition step S2-1). Furthermore, the present invention may also include a further step of obtaining test sample information about the test sample after the containment step and before the cell culture step (hereinafter referred to as the first test sample information acquisition step S1-1). Furthermore, the present invention may also include a first test sample information acquisition step S1-1 or the second test sample information acquisition step S2-1.
[0150] The first sample information acquisition process S1-1 and the second sample information acquisition process S2-1 will be explained in more detail below, with reference to Figure 1.
[0151] (3-1) First test sample information acquisition process S1-1, second test sample information acquisition process S2-1 (3-1-1) Regarding the first test sample information acquisition process and the second test sample information acquisition process, the first test sample information acquisition process S1-1 is a process in which first test sample information is obtained regarding the test sample after the containment process S1 and before the cell culture process S2.
[0152] Furthermore, a preliminary cell culture step may be performed before the first test sample information acquisition step S1-1. Here, it is preferable that the preliminary cell culture step be performed under the same conditions as the cell culture step S2. However, it is preferable that the cell culture time be shorter than that of the cell culture step S2.
[0153] Furthermore, the second test sample information acquisition step S2-1 is a step in which second test sample information regarding the test sample is obtained after the cell culture step S2.
[0154] Here, the second test sample information acquisition step S2-1 may be preceded by a cell fixation treatment using paraformaldehyde, glutaraldehyde, alcohol, dimethyl sveriminoate, etc.
[0155] In this case, it is preferable that the cell detection step S3 includes a step of comparing the first test sample information acquisition step S1-1 and the second test sample information acquisition step S2-1 to determine that cells are present in the test sample if cells have proliferated in at least one microchamber structure.
[0156] Furthermore, the cell detection step S3 may include a cell identification step that identifies the proliferating cell types based on the first test sample information acquisition step S1-1 and / or the second test sample information acquisition step S2-1.
[0157] The cell quantification step S3 preferably includes a measurement process that measures the number of microchamber structures containing the cell species to be quantified based on the first test sample information acquisition step S1-1 and / or the second test sample information acquisition step S2-1, and a quantification process that quantifies the cells in the test sample based on the increase in the number of microchamber structures containing the cell species to be quantified.
[0158] Here, the cell types to be quantified may be predetermined. Alternatively, based on the first sample information acquisition step S1-1 and / or the second sample information acquisition step S2-1, the proliferating cell types may be identified, and the identified cell types may be used for quantification.
[0159] There is no particular limit to the number of cell species to be quantified; one or more species are sufficient. If two or more cell species are to be quantified, it is preferable to perform the measurement process and the quantification process for each cell species.
[0160] (3-1-2) Method of acquiring information in the first and second sample information acquisition steps In the first sample information acquisition step S1-1 and the second sample information acquisition step S2-1, it is preferable to use one or more pieces of information selected from the following pieces of information ((i) image information, (ii) fluorescence information, (iii) luminescence information, (iv) luminosity information, light intensity information, turbidity information).
[0161] (i) Image information: Image information refers to information obtained by imaging the microchamber structure. As for the method of acquiring image information, if the first sample information acquisition step S1-1 and the second sample information acquisition step S2-1 are image information obtained by imaging the microchamber structure, then the method of acquiring the image can be said to be the method of acquiring the image using an imaging device.
[0162] Here, the unit for image acquisition may be one image for each microchamber structure, multiple images for each microchamber structure, or images for all microchamber structures.
[0163] Furthermore, there are no particular restrictions on the number of times images can be acquired. For example, images can be acquired over time.
[0164] In this case, by acquiring images using a high-magnification microscope, cell types can be identified from the images. Examples of such imaging devices include the benchtop imaging system APX100 (manufactured by Evident Co., Ltd.), the inverted research microscope IX83 (Olympus Corporation), a combination of the high-sensitivity sCMOS camera Neo (ANDOR Corporation) and the 20x objective lens LUCPLFLN20XPH (Olympus Corporation), and the culture microscope CKX53 (Olympus Corporation).
[0165] Furthermore, for analyzing image information, image analysis software commonly used for analyzing cell image information, such as ImageJ, Fiji, and CellProfiler, may be used.
[0166] For example, the microchamber structure in images acquired over time from the same field of view may be set as a region of interest (ROI), and changes in fluorescence information, luminescence information, photometric information, light intensity information, and turbidity information in the ROI may be extracted over time. By extracting these changes over time, target cells can be rapidly detected. Alternatively, all microchamber structures can be set as regions of interest. As a result, the microchamber structures in which target cells are detected can be easily counted, thus enabling easy quantification of target cells.
[0167] (ii) Fluorescence Information Fluorescence information refers to information about fluorescence within the microchamber structure. As for the method of acquiring fluorescence information, if the first sample information acquisition step S1-1 and the second sample information acquisition step S2-1 are about fluorescence information within the microchamber structure, fluorescence information within the microchamber structure is acquired using a spectrofluorometer or fluorescence microscope. As for the fluorescence microscope, it is preferable to use a benchtop imaging system APX100 (manufactured by Evident Co., Ltd.) or a device that can perform measurements with high precision and high speed. For example, a combination of an inverted research microscope IX83 (Olympus Corporation) as the microscope body, Xcite XYLIS (EXCELITAS TECHNOLOGIES) as the excitation LED light source unit, Neo (ANDOR Corporation) as the high-sensitivity sCMOS camera, and LUCPLFLN20XPH (Olympus Corporation) as the 20x objective lens can be cited.
[0168] Furthermore, when acquiring fluorescence information, it is preferable to add a staining agent for fluorescently staining cells into the microchamber structure before the first sample information acquisition step S1-1 and / or the second sample information acquisition step S2-1.
[0169] Here, the staining agent used to fluorescently stain the cells can be the same as described in cell staining step S2. Alternatively, immunocytochemistry may be used to obtain the fluorescence information.
[0170] Furthermore, by using fluorescently labeled antibodies against surface antigens specific to each cell type, it is possible to identify the cell type based on fluorescence information.
[0171] (iii) Luminescence Information Luminescence information refers to information relating to luminescence within the microchamber structure. If the first sample information acquisition step S1-1 and the second sample information acquisition step S2-1 involve luminescence information within the microchamber structure, the luminescence information within the microchamber structure is acquired using a luminometer or the like.
[0172] Furthermore, means of causing cells to emit light include using an ATP measuring reagent. When acquiring luminescence information, it is preferable to add the ATP measuring reagent into the microchamber structure before the first test sample information acquisition step S1-1 and / or the second test sample information acquisition step S2-1.
[0173] (iv) Luminous intensity information, light intensity information, and turbidity information. Luminous intensity information refers to information about the luminous intensity within the microchamber structure. Light intensity information refers to information about the light intensity within the microchamber structure. Turbidity information refers to information about the turbidity within the microchamber structure. Here, the above information can be obtained by known means.
[0174] <2> Cell detection and / or quantification kit The cell detection and / or quantification kit of the present invention comprises a substrate having a microchamber structure, and a medium or oily sealant to which the test sample can adhere, or a medium to which the test sample can adhere and which has a microchamber structure.
[0175] The cell detection and / or quantification kit of the present invention enables faster and simpler detection and / or quantification of cells.
[0176] Furthermore, the above-described explanations of the cell detection and / or quantification kit of the present invention, the preferred embodiments of each component, and each step of the cell detection and / or quantification method can be applied by reference.
[0177] <3> Cell detection and / or quantification apparatus Next, the cell detection and / or quantification apparatus of the present invention will be described with reference to Figure 8.
[0178] The cell detection and / or quantification apparatus of the present invention comprises a measurement target placement section 41 on which a measurement target 42 can be placed, a base section 43 having at least one measurement target placement section 41, and an information acquisition means placement section 44 on which a means for acquiring a test sample information relating to the test sample can be placed from the measurement target 42 placed in the measurement target placement section 41, wherein the base section 43 has a movable mechanism 45 that can move the measurement target placement section 41 to a position corresponding to the information acquisition means placement section 44.
[0179] The measurement target 42 is a substrate having a microchamber structure, and a medium or oily sealant to which the test sample can adhere, or a medium to which the test sample can adhere and which has a microchamber structure. The measurement target 42 may also be a cell detection and / or quantification kit as described in <Cell Detection and / or Quantification Kit>.
[0180] The measurement target placement section 41 has a configuration that allows the measurement target 42 to be placed. The measurement target placement section 41 can, for example, take the form of a frame that conforms to the contour of the measurement target 42.
[0181] Furthermore, the measurement target placement section 41 is located on the base section 43. The base section 43 only needs to have at least one measurement target placement section 41, and may have multiple measurement target placement sections 41.
[0182] By providing multiple measurement target placement sections 41 on the base section 43, it becomes unnecessary to replace the measurement target 42 after each measurement.
[0183] The information acquisition means placement unit 44 is positioned so that when an information acquisition means is placed in the information acquisition means placement unit 44, it can acquire various types of information from the measurement target 42 placed in the measurement target placement unit 41. By placing the information acquisition means placement unit 44 on top of the measurement target 42 placed in the measurement target placement unit 41, it is possible to obtain sample information related to the test sample from the measurement target 42.
[0184] The information acquisition means arrangement section 44 may, for example, include a frame portion shaped to match the contour of the sample information acquisition means. The information acquisition means arrangement section 44 may also have holes that allow various types of information to be acquired from the measurement target 42 arranged in the measurement target arrangement section 41.
[0185] Here, examples of means for acquiring information on the sample under test include an imaging device, a spectrofluorometer, a fluorescence microscope, and a spectrophotometer. Depending on the type of means for acquiring information on the sample under test, an appropriate light source or the like may be installed below the measurement target placement section 41.
[0186] The movable mechanism 45 is installed below the base portion 43 and can move the measurement target placement portion 41 to a position corresponding to the information acquisition means placement portion 44. The movable mechanism 45 can be, for example, a rotating mechanism that moves the measurement target placement portion 41 to a position corresponding to the information acquisition means placement portion 44.
[0187] Furthermore, the cell detection and / or quantification device of the present invention may also include a temperature control unit 46 and / or a constant temperature culture unit 47.
[0188] By including a temperature control unit 46 and / or a constant temperature culture unit 47, it becomes possible to acquire information on the test sample over a long period of time.
[0189] Furthermore, the cell detection and / or quantification device of the present invention may also include an information acquisition means movable unit 48.
[0190] By providing the movable information acquisition means 48 below the information acquisition means placement section 44, the information acquisition means can be finely adjusted when acquiring information about the sample being tested, thereby obtaining optimal sample information.
[0191] By using the above configuration for the cell detection and / or quantification device, cell detection and / or quantification can be performed more quickly and easily.
[0192] Furthermore, the above-described explanations of the cell detection and / or quantification device of the present invention can be applied by reference to the explanations of the cell detection and / or quantification device of the present invention, the preferred embodiments of each configuration, each step of the cell detection and / or quantification method, and the cell detection and / or quantification kit.
[0193] <4> Solid medium for cell detection and / or quantification The solid medium for cell detection and / or quantification of the present invention is a solid medium for cell detection and / or quantification in which 50 to 100 million microchamber structures are arranged in the solid medium, and the volume of the microchamber structure is 0.01 femtoliters to 500 nanoliters.
[0194] By using a solid culture medium having the above configuration, cells can be detected and / or quantified quickly and easily.
[0195] Furthermore, the above-described descriptions of the cell detection and / or quantification method, preferred embodiments of each component, each step of the cell detection and / or quantification method, the cell detection and / or quantification kit, and the cell detection and / or quantification apparatus can be applied to the solid culture medium for cell detection and / or quantification of the present invention.
[0196] <5> Method for producing a solid culture medium for cell detection and / or quantification The present invention provides a method for producing a solid culture medium for cell detection and / or quantification, which includes forming a microchamber structure in a solid culture medium using a mold having a volume of 0.01 femtoliters or more and 500 nanoliters or less, and containing 50 to 100 million microchamber-forming structures.
[0197] By using the solid culture medium obtained by the above manufacturing method, cells can be detected and / or quantified quickly and easily.
[0198] Furthermore, in the method for producing a solid culture medium for cell detection and / or quantification of the present invention, the above-mentioned descriptions of the <Method for Cell Detection and / or Quantification>, <Preferred Embodiments of Each Configuration>, <Each Step of the Method for Cell Detection and / or Quantification>, <Kit for Cell Detection and / or Quantification>, <Apparatus for Cell Detection and / or Quantification>, and <Solid Culture Medium for Cell Detection and / or Quantification> can be applied.
[0199] The present invention will be specifically described below with reference to examples, but the technical scope of the present invention is not limited to the following embodiments.
[0200] <Manufacturing Example 1> Manufacturing of a Substrate with Microchamber Structure A cover glass with a diameter of 60 μm, a height of 50 μm, a volume of 0.14 nanoliters, and 144,000 microchamber-forming structures was manufactured using photolithography. Next, nutrient broth agar medium (Beef Extract 0.3% by mass, Peptone 0.5% by mass, Agar 1.5% by mass) was used as the substrate. Specifically, 20 mL of autoclaved nutrient broth agar medium was placed in a petri dish. Then, before the nutrient broth agar medium completely solidified, the cover glass with microchamber-forming structures was placed on the surface of the nutrient broth agar medium. After the nutrient broth agar medium solidified, the cover glass with microchamber-forming structures was removed to manufacture a substrate with a volume of 0.14 nanoliters and 144,000 microchamber-forming structures (in this case, the substrate was nutrient broth agar medium).
[0201] <Test Example 1> (1) Preparation of the membrane filter to which the test sample is attached. The culture solution of Pseudomonas aeruginosa, pre-cultured in nutrient broth medium, is 1.6 × 10⁻⁶. 3 The culture medium was adjusted to cells / mL. Next, 1 mL of the prepared culture medium was filtered through a membrane filter with a pore size of 0.4 μm, and the test sample was allowed to adhere to the membrane filter.
[0202] (2) Containment process The membrane filter to which the test sample prepared in (1) was attached was placed on a substrate having a microchamber structure prepared in Preparation Example 1 and cultured at 30°C. As a negative control, the membrane filter to which the test sample prepared in (1) was attached was placed on a substrate without a microchamber structure and cultured in the same manner.
[0203] (3) Results Using a phase-contrast microscope CKX53 (Olympus Corporation), substrates with a microchamber structure and substrates without a microchamber structure were observed over time. Figure 9 shows the results after 9 hours of incubation, Figure 10 shows the results after 12 hours, Figure 11 shows the results after 15 hours, and Figure 12 shows the results after 16 hours.
[0204] (4) Discussion Figures 9 to 12 show that by using a substrate having the above-described microchamber structure, cells can be rapidly detected 9 hours after the start of culture.
[0205] This is thought to be because, by using a microchamber structure with the above-described morphology, cells are compelled to form colonies within the microchamber structure. As a result, the cells were visualized as colonies at an early stage.
[0206] Furthermore, Figures 9 to 12 show that the number of microchamber structures in which cells were detected could be counted. Therefore, it can be inferred that the number of microchamber structures in which cells were detected were Pseudomonas aeruginosa contained in the membrane filter prepared in (1).
[0207] Therefore, it was found that cells can be quantified by using a substrate having a microchamber structure with the above-described form.
[0208] <Manufacturing Example 2> Manufacturing of a substrate with a microchamber structure Following Manufacturing Example 1, soybean casein digest agar medium (Pancreatic Digest of Casein 1.5% by mass, Pancreatic Digest of Soybean Meal 0.5% by mass, Sodium Chloride 0.5% by mass, Agar 1.5% by mass) was used as the substrate instead of nutrient broth agar medium. This resulted in the production of a substrate with a microchamber structure (in this case, the substrate was soybean casein digest agar medium).
[0209] <Test Example 2> (1) Preparation of the test sample In Test Example 2, Pseudomonas aeruginosa was used as the cells to be detected and / or quantified. First, Pseudomonas aeruginosa was cultured in soybean casein digest liquid medium (Pancreatic Digest of Casein 1.7% by mass, Papaic Digest of Soybean Meal 0.3% by mass, Sodium Chloride 0.5% by mass, Dipotassium Phosphate 0.25% by mass, Glucose 0.25% by mass) to obtain 0.8-1.6 × 10⁻⁶ Pseudomonas aeruginosa. 6 The cells were cultured until the cell count reached 4 / mL.
[0210] (2) Preparation of mammalian cells Also, as cells not subject to detection and / or quantification, MDCK (Madrin-Darby Canine) was prepared using 10% FBS / DMEM medium (DEM (Dulbecco's Modified Eagle's Medium, 25 mM gluten, hereinafter referred to as DMEM) medium (manufactured by Fujifilm Wako Pure Chemical Industries, Ltd., Cat: 044-29765), 10% FBS (fetal bovine serum) (Thermo Fisher Scientific Inc., Cat: 10270-10), 100 units / mL penicillin, 100 μg / mL streptomycin (Thermo Fisher Scientific Inc., Cat: 15140-163). Kidney cells were passaged six times and cultured in a 10 cm dish until confluent. The culture medium was removed from the confluent 10 cm dish, 3 mL of trypsin EDTA solution (Thermo Fisher Scientific, Cat: 25200056) was added, and the mixture was allowed to stand at 37°C for 15 minutes to detach the cells. Next, 5 mL of DMEM medium (Fujifilm Wako Pure Chemical Industries, Ltd., Cat: 044-29765) was added, and the entire volume was transferred to a 15 mL tube. The mixture was then centrifuged at 200 × g at room temperature for 5 minutes, and the supernatant was removed. Subsequently, 1 mL of PBS (Phosphate-Buffered Saline) was added, and the cells were transferred to a 1.5 mL tube with low protein adsorption. Next, the mixture was centrifuged at 200 x g at room temperature for 5 minutes, the supernatant was removed, and 1 mL of PBS was added (hereinafter referred to as the Wash procedure). The Wash procedure was repeated twice. Then, after centrifuging at 200 x g at room temperature for 5 minutes, the supernatant was removed, 300 μL of PBS was added, and the mixture was dispensed into 100 μL portions (hereinafter also referred to as MDCK cells in PBS).
[0211] (3) Containment Step Three mixtures were prepared by mixing 10 μL of Pseudomonas aeruginosa culture solution prepared in (1) with 100 μL of MDCK cells in PBS prepared in (2) (hereinafter also referred to simply as the mixture). Next, the entire volume of the mixture was added to the following media (A) to (C). (A) Soybean casein digest agar medium without a microchamber structure (B) Soybean casein digest agar medium without a microchamber structure (C) Soybean casein digest agar medium with a microchamber structure prepared in Production Example 2
[0212] The culture media (A) to (C) described above were allowed to stand for 10 minutes to dry. Then, 200 μL each of TEGOSOFT® DEC (Evonik Operations GmbH, diethylhexyl carbonate) was added to culture media (B) and (C) as an oily sealant, thereby sealing the microchamber structure in (C). Time-lapse observations of culture media (A), (B), and (C) were then performed using a benchtop imaging system APX100 (Evident Co., Ltd.) heated to 30°C.
[0213] (4) Results of time-lapse observation The results of the observation of culture medium (A) are shown in Figure 13, the results of the observation of culture medium (B) are shown in Figure 14, and the results of the observation of culture medium (C) are shown in Figure 15. From Figures 13 and 14, Pseudomonas aeruginosa, which was the target of detection and / or quantification, was growing regardless of the presence or absence of TEGOSOFT DEC. From Figure 14, colonies of Pseudomonas aeruginosa could be confirmed from 8 hours after the containment process. Furthermore, from Figure 15, the microchamber structure in which Pseudomonas aeruginosa was growing could be observed from 6 to 7 hours after the containment process.
[0214] (5) Discussion Figures 13 to 15 show that even in the presence of cells that are not the target of detection and / or quantification, by using a substrate having the above-described microchamber structure, cells that are the target of detection and / or quantification can be rapidly detected 6 to 7 hours after the containment process.
[0215] <Analysis Example 1> Image Analysis of Example 2 (1) Method Using Fiji, 13 arbitrary locations (n=13) were selected from Figures 13 and 14, and 23 microchamber structures (n=23) were selected from Figure 15. A region of interest (ROI) of 8 pixels in diameter was then created for each. The mean gray value of each ROI was measured and plotted from 0 to 12 hours after the containment process.
[0216] (2) Results The plot results from Figure 13 are shown in Figure 16, the plot results from Figure 14 are shown in Figure 17, and the results from Figure 15 are shown in Figure 18. From Figures 16 and 17, the Mean gray value decreased from 7 hours after the containment process in 10 out of 13 locations, and Pseudomonas aeruginosa proliferated regardless of the presence or absence of TEGOSOFT DEC. From Figure 18, the Mean gray value decreased from 5 hours after the containment process in 20 out of 23 microchamber structures, and Pseudomonas aeruginosa proliferated.
[0217] (3) Discussion Figures 16 and 17 show that TEGOSOFT DEC does not substantially inhibit the growth of Pseudomonas aeruginosa targeted for detection and / or quantification. Furthermore, Figures 16 to 18 show that even in the presence of cells not targeted for detection and / or quantification, by using a substrate with the above-described microchamber structure, cells targeted for detection and / or quantification can be rapidly detected 5 hours after the containment process.
[0218] Furthermore, Figure 18 shows that even in the presence of cells not targeted for detection and / or quantification, the number of microchamber structures in which the target cells were proliferating can be counted. Therefore, by performing the same analysis as in Analysis Example 1 for all microchamber structures, the number of microchamber structures in which cells were proliferating can be quantified. It can then be inferred that the number of microchamber structures represents Pseudomonas aeruginosa contained in the test sample.
[0219] <Test Example 3> (1) Preparation of the test sample In Test Example 3, Pseudomonas aeruginosa was used as the cell to be detected and / or quantified. First, as in Test Example 2, Pseudomonas aeruginosa was prepared at a density of 0.8 to 1.6 × 10⁻⁶. 6 The cells were cultured until the cell count reached 4 / mL.
[0220] (2) Containment process Four samples were prepared by adding 10 μL of the Pseudomonas aeruginosa culture solution prepared in (1) to soybean casein digest agar medium having a microchamber structure, which was produced in Production Example 2.
[0221] The four culture media were allowed to stand for 10 minutes to dry. Then, the microchamber structure was sealed by applying 200 μL each of the following four oily sealants: ・TEGOSOFT® DEC (manufactured by Evonik Operations GmbH, hereafter referred to as diethylhexyl carbonate) ・Mineral oil (manufactured by Merck KGaA, Cat: 34-0013-5) ・Olive oil (manufactured by J-Oil Mills Co., Ltd., extra virgin olive oil) ・Fomblin® Oil (manufactured by Solvay S.A., Cat: YL VAC 06 / 6, hereafter referred to as perfluoropolyether oil) Time-lapse observation of each culture medium was then performed using a benchtop imaging system APX100 (manufactured by Evident Co., Ltd.) heated to 30°C.
[0222] (3) Results of time-lapse observation Figure 19 shows the observation results of the culture media coated with each oily sealant. The observation results shown in Figure 19 are 7 hours after the containment process for diethylhexyl carbonate and mineral oil, 8 hours after the containment process for perfluoropolyether oil, and 9 hours after the containment process for olive oil. From Figure 19, it was possible to observe the microchamber structure in which Pseudomonas aeruginosa had proliferated 7 to 9 hours after the containment process, regardless of the type of oily sealant.
[0223] (4) Discussion Figure 19 shows that, regardless of the type of oil-based encapsulant, by using a substrate having the above-described microchamber structure, cells to be detected and / or quantified can be rapidly detected 7 to 9 hours after the containment process.
[0224] This invention can be applied to sterility testing of products and pharmaceuticals.
[0225] 21 Medium 22 Microchamber structure 23 Substrate 24 Culture medium 25 Cells 31 Test sample 4 Cell detection and / or quantification device 41 Measurement target placement section 42 Measurement target 43 Base section 44 Information acquisition means placement section 45 Movable mechanism 46 Temperature control section 47 Constant temperature culture section 48 Movable section for information acquisition means 51 Sealing material
Claims
1. A method for detecting and / or quantifying cells, comprising: a cell culture step or a cell staining step; a cell detection step for detecting the presence or absence of cells in a microchamber structure and / or a cell quantification step for quantifying cells.
2. A method for detecting and / or quantifying cells according to claim 1, comprising a containment step of containing a test sample in the microchamber structure before the cell culture step or the cell staining step, wherein the containment step includes a sealing process of sealing with an oily sealant.
3. A method for detecting and / or quantifying cells according to claim 1 or 2, comprising a containment step of containing a test sample in the microchamber structure before the cell culture step or the cell staining step, wherein the containment step includes a containment process of containing the test sample in the microchamber structure via a medium to which the test sample is attached.
4. The method for detecting and / or quantifying cells according to claim 2, wherein 50 to 100 million microchamber structures are arranged, the volume of the microchamber structures is 0.01 femtoliters to 500 nanoliters, and the microchamber structures are arranged on the surface of a solid culture medium.
5. The method for detecting and / or quantifying cells according to claim 3, wherein 50 to 100 million microchamber structures are arranged, the volume of the microchamber structures is 0.01 femtoliters to 500 nanoliters, the medium is a membrane filter or adhesive tape, and the microchamber structures are arranged on the surface of a solid culture medium.
6. A method for detecting and / or quantifying cells according to claim 2, further comprising: a first test sample information acquisition step for obtaining first test sample information relating to the test sample after the containment step and before the cell culture step; and a second test sample information acquisition step for obtaining second test sample information relating to the test sample after the cell culture step, wherein the cell detection step includes a step of comparing the first test sample information and the second test sample information to determine that cells are present in the test sample if cells have proliferated in at least one of the microchamber structures; and the cell quantification step includes a measurement process for measuring the number of microchamber structures in which the target cell species exists based on the first test sample information and / or the second test sample information; and a quantification process for quantifying the cells in the test sample based on the increase in the number of microchamber structures in which the target cell species exists.
7. The cell detection and / or quantification method according to claim 6, wherein the first test sample information and the second test sample information are image information of a microchamber structure, fluorescence information within the microchamber structure, luminescence information within the microchamber structure, absorbance information within the microchamber structure, light intensity information within the microchamber structure, and / or turbidity information within the microchamber structure.
8. The cell detection and / or quantification method according to claim 3, wherein the containment step includes a containment process, the containment process being a process of containing the sample in the microchamber structure by grounding the medium to which the sample has been attached, using a detection and / or quantification kit that includes a substrate having a microchamber structure and a medium to which the sample can be attached, or the containment process being a process of containing the sample in the microchamber structure by attaching the sample to the medium, using a detection and / or quantification kit that includes a medium to which the sample can be attached and which has a microchamber structure.
9. A detection and / or quantification kit for detecting and / or quantifying cells, comprising: a substrate having a microchamber structure; and a medium or oily sealant to which a test sample can adhere, or a medium to which a test sample can adhere and which has a microchamber structure.
10. A cell detection and / or quantification device, comprising: a substrate having a microchamber structure; a measurement target placement section on which a measurement target having a medium or oily sealant to which a test sample can adhere, or a medium to which a test sample can adhere and which has a microchamber structure can be placed; a base section having at least one of the measurement target placement sections; and an information acquisition means placement section on which a test sample information acquisition means for obtaining test sample information relating to the test sample from the measurement target placed in the measurement target placement section can be placed, wherein the base section has a movable mechanism that allows the measurement target placement section to be moved to a position corresponding to the information acquisition means placement section.
11. A solid culture medium for cell detection and / or quantification, wherein the solid culture medium is arranged with 50 to 100 million microchamber structures, and the volume of the microchamber structures is 0.01 femtoliters to 500 nanoliters.
12. A method for producing a solid culture medium, comprising forming a microchamber structure in the solid culture medium using a mold having a volume of 0.01 femtoliters or more and 500 nanoliters or less, and containing 50 to 100 million microchamber-forming structures.
